BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 9027600)

  • 1. Application of molecular epidemiology to lung cancer chemoprevention.
    Mooney LA; Perera FP
    J Cell Biochem Suppl; 1996; 25():63-8. PubMed ID: 9027600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Individual susceptibility to occupational carcinogens: the evidence from biomonitoring and molecular epidemiology studies].
    Pavanello S; Clonfero E
    G Ital Med Lav Ergon; 2004; 26(4):311-21. PubMed ID: 15584438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lung cancer chemoprevention: an integrated approach.
    Lippman SM; Spitz MR
    J Clin Oncol; 2001 Sep; 19(18 Suppl):74S-82S. PubMed ID: 11560978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The association between lung and prostate cancer risk, and serum micronutrients: results and lessons learned from beta-carotene and retinol efficacy trial.
    Goodman GE; Schaffer S; Omenn GS; Chen C; King I
    Cancer Epidemiol Biomarkers Prev; 2003 Jun; 12(6):518-26. PubMed ID: 12814997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of vitamin intervention on the relationship between GSTM1, smoking, and lung cancer risk among male smokers.
    Woodson K; Stewart C; Barrett M; Bhat NK; Virtamo J; Taylor PR; Albanes D
    Cancer Epidemiol Biomarkers Prev; 1999 Nov; 8(11):965-70. PubMed ID: 10566550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of diet on DNA bulky adduct levels are strongly modified by GSTM1 genotype: a study on 634 subjects.
    Palli D; Masala G; Peluso M; Gaspari L; Krogh V; Munnia A; Panico S; Saieva C; Tumino R; Vineis P; Garte S
    Carcinogenesis; 2004 Apr; 25(4):577-84. PubMed ID: 14656945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carcinogen biomarkers for lung or oral cancer chemoprevention trials.
    Hecht SS
    IARC Sci Publ; 2001; 154():245-55. PubMed ID: 11220664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The molecular epidemiology of lung cancer.
    Schwartz AG; Prysak GM; Bock CH; Cote ML
    Carcinogenesis; 2007 Mar; 28(3):507-18. PubMed ID: 17183062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GSTM1 and CYP1A1 polymorphisms, tobacco, air pollution, and lung cancer: a study in rural Thailand.
    Pisani P; Srivatanakul P; Randerson-Moor J; Vipasrinimit S; Lalitwongsa S; Unpunyo P; Bashir S; Bishop DT
    Cancer Epidemiol Biomarkers Prev; 2006 Apr; 15(4):667-74. PubMed ID: 16614107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Environmental and chemical carcinogenesis.
    Wogan GN; Hecht SS; Felton JS; Conney AH; Loeb LA
    Semin Cancer Biol; 2004 Dec; 14(6):473-86. PubMed ID: 15489140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic polymorphisms as susceptibility markers for lung and oral cavity cancer.
    Nair U; Bartsch H
    IARC Sci Publ; 2001; 154():271-90. PubMed ID: 11220667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. G-actin as a risk factor and modulatable endpoint for cancer chemoprevention trials.
    Hemstreet GP; Rao J; Hurst RE; Bonner RB; Waliszewski P; Grossman HB; Liebert M; Bane BL
    J Cell Biochem Suppl; 1996; 25():197-204. PubMed ID: 9027619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carcinogen-DNA and protein adducts: biomarkers for cohort selection and modifiable endpoints in chemoprevention trials.
    Kensler TW; Groopman JD
    J Cell Biochem Suppl; 1996; 25():85-91. PubMed ID: 9027603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediagnostic levels of serum beta-cryptoxanthin and retinol predict smoking-related lung cancer risk in Shanghai, China.
    Yuan JM; Ross RK; Chu XD; Gao YT; Yu MC
    Cancer Epidemiol Biomarkers Prev; 2001 Jul; 10(7):767-73. PubMed ID: 11440962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Individual predisposition to lung neoplasm--the role of genes involved in metabolism of carcinogens].
    Butkiewicz D; Chorazy M
    Postepy Hig Med Dosw; 1999; 53(5):655-73. PubMed ID: 10645142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum insulin-like growth factor (IGF) and IGF-binding protein levels and risk of lung cancer: a case-control study nested in the beta-Carotene and Retinol Efficacy Trial Cohort.
    Spitz MR; Barnett MJ; Goodman GE; Thornquist MD; Wu X; Pollak M
    Cancer Epidemiol Biomarkers Prev; 2002 Nov; 11(11):1413-8. PubMed ID: 12433720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preoperative levels of plasma micronutrients are related to endometrial cancer risk.
    Jeong NH; Song ES; Lee JM; Lee KB; Kim MK; Yun YM; Lee JK; Son SK; Lee JP; Kim JH; Hur SY; Kwon YI
    Acta Obstet Gynecol Scand; 2009; 88(4):434-9. PubMed ID: 19235557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surrogate end-point biomarker analysis in a retinol chemoprevention trial in current and former smokers with bronchial dysplasia.
    Lam S; Xu X; Parker-Klein H; Le Riche JC; Macaulay C; Guillaud M; Coldman A; Gazdar A; Lotan R
    Int J Oncol; 2003 Dec; 23(6):1607-13. PubMed ID: 14612933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biological relevance of adduct detection to the chemoprevention of cancer.
    Sharma RA; Farmer PB
    Clin Cancer Res; 2004 Aug; 10(15):4901-12. PubMed ID: 15297390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic polymorphism of CYP genes, alone or in combination, as a risk modifier of tobacco-related cancers.
    Bartsch H; Nair U; Risch A; Rojas M; Wikman H; Alexandrov K
    Cancer Epidemiol Biomarkers Prev; 2000 Jan; 9(1):3-28. PubMed ID: 10667460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.